ELCIX
Price
$48.27
Change
-$0.06 (-0.12%)
Updated
Jun 4 closing price
Net Assets
462.37M
GFACX
Price
$73.39
Change
+$0.12 (+0.16%)
Updated
Jun 4 closing price
Net Assets
337.53B
Interact to see
Advertisement

ELCIX vs GFACX

Header iconELCIX vs GFACX Comparison
Open Charts ELCIX vs GFACXBanner chart's image
ELCIX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
ELCIX vs. GFACX commentary
Jun 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELCIX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 338B vs. ELCIX (462M). ELCIX (0.00) and GFACX (0.00) have matching dividends . ELCIX was incepted earlier than GFACX: ELCIX (19 years) vs GFACX (25 years). GFACX (1.35) is less costly to investors than ELCIX (0.79). GFACX is a more actively managed with annual turnover of: 32.00 vs. ELCIX (20.00). GFACX has a lower initial minimum investment than ELCIX: GFACX (250) vs ELCIX (1000000). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. ELCIX (6.95). ELCIX return over 5 years is better than : 19.48 vs. GFACX (12.44).
ELCIXGFACXELCIX / GFACX
Total Expense Ratio0.791.3559%
Annual Report Gross Expense Ratio0.791.3559%
Fund Existence19 years25 years-
Gain YTD7.9289.04988%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets462M338B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.9510.1568%
Returns for 3 years43.1243.3499%
Returns for 5 years19.4812.44157%
Returns for 10 years110.7785.14130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLN6.850.44
+6.86%
Silence Therapeutics Plc
RNG44.030.06
+0.14%
RINGCENTRAL
TPL406.73-0.03
-0.01%
Texas Pacific Land Corporation
SSII3.84-0.47
-10.90%
SS Innovations International Inc
BMGL0.49-0.17
-26.06%
Basel Medical Group Ltd